Clinical efficacy and safety of weekly paclitaxel therapy as second-line chemotherapy for patients with advanced and recurrent gastric cancer who were previously treated with TS-1 therapy

Gan to kagaku ryoho. Cancer & chemotherapy

Volumn 33, Issue 9, 2006, Pages 1257-1260

  Hatori, Shinsuke ^a   Kunisaki, Chikara ^a   Ono, Hidetaka ^a   Sato, Tsutomu ^a   Otsuka, Yuichi ^a   Yamada, Roppei ^a   Ohshima, Takashi ^a   Rino, Yasushi ^a   Imada, Toshio ^a  

^a YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; OXONIC ACID; PACLITAXEL; S 1 (COMBINATION); TEGAFUR;

AGED; ALOPECIA; ARTICLE; CHEMICALLY INDUCED DISORDER; DRUG ADMINISTRATION; DRUG COMBINATION; FEMALE; HUMAN; LEUKOPENIA; MALE; MIDDLE AGED; MORTALITY; QUALITY OF LIFE; STOMACH TUMOR; SURVIVAL RATE; TUMOR RECURRENCE;

AGED; ALOPECIA; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; FEMALE; HUMANS; LEUKOPENIA; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OXONIC ACID; PACLITAXEL; QUALITY OF LIFE; STOMACH NEOPLASMS; SURVIVAL RATE; TEGAFUR;

EID: 33749322003     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)